PYXIS ONCOLOGY INC (PYXS) Institutional Ownership Changes & 13F Activity
PYXIS ONCOLOGY INC (PYXS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Gordonmd Global Investments Lp, Woodline Partners Lp, Marshall Wace, Llp, 683 Capital Management, Llc, and Millennium Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -13,932 | -22.7% | 47,317 | $142.42K | Q2 2026 | Sep 02, 2026 |
| Palo Alto Investors Lp | Sell | -146,233 | -14.5% | 864,277 | $2.60M | Q2 2026 | Aug 19, 2026 |
| Gordonmd Global Investments Lp | Buy | +5,903,039 | +143.2% | 10,024,909 | $30.17M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +523,999 | — | 523,999 | $1.58M | Q2 2026 | Aug 14, 2026 |
| 683 Capital Management, Llc | Sell | -436,896 | -48.7% | 459,367 | $1.38M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -164,621 | -41.4% | 233,004 | $701.34K | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Sell | -149,632 | -29.7% | 353,582 | $1.06M | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Sell | -89,157 | -44.6% | 110,939 | $333.93K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +63,657 | +378.8% | 80,464 | $242.20K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -45,156 | -90.6% | 4,669 | $14.05K | Q2 2026 | Aug 14, 2026 |
| Verdad Advisers, Lp | Buy | +44,899 | — | 44,899 | $135.15K | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Buy | +38,646 | +342.4% | 49,932 | $150.29K | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -32,391 | -7.0% | 428,606 | $1.29M | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Buy | +16,480 | — | 16,480 | $49.60K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -14,369 | -4.7% | 290,090 | $873.17K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +10,661 | +14.5% | 83,961 | $252.72K | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Buy | +5,086 | +15.9% | 37,092 | $111.65K | Q2 2026 | Aug 14, 2026 |
| Federation Des Caisses Desjardins Du Quebec | Buy | +4,500 | — | 4,500 | $13.54K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +4,000 | +29.2% | 17,721 | $53.34K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -1,020 | -2.2% | 45,900 | $138.16K | Q2 2026 | Aug 14, 2026 |
| Graham Capital Management, L.P. | Sell | -40 | -0.2% | 22,708 | $68.35K | Q2 2026 | Aug 14, 2026 |
| Marshall Wace, Llp | Buy | +476,127 | +134.3% | 830,544 | $2.50M | Q2 2026 | Aug 13, 2026 |
| Renaissance Technologies LLC | Sell | -116,448 | -13.1% | 772,232 | $2.32M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -98,907 | -38.9% | 155,217 | $467.20K | Q2 2026 | Aug 13, 2026 |
| Laurion Capital Management Lp | Sell | -96,445 | -1.9% | 4,900,888 | $14.75M | Q2 2026 | Aug 13, 2026 |
| Myda Advisors Llc | Buy | +50,000 | — | 50,000 | $150.50K | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +42,487 | +2.1% | 2,075,997 | $6.25M | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -36,240 | -52.0% | 33,448 | $100.68K | Q2 2026 | Aug 13, 2026 |
| Mackenzie Financial Corp | Buy | +26,343 | — | 26,343 | $79.29K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +22,011 | +21.6% | 123,959 | $373.12K | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about PYXS activity
Which institutional owners are buying PYXS?
Institutional owners buying PYXS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PYXS activity?
"Buy" means an investor increased their reported position in PYXS compared to the prior reporting period. This reflects growing exposure to PYXIS ONCOLOGY INC (PYXS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PYXS increasing?
Institutional interest in PYXS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related PYXS Institutional Insights
- PYXS Overview
- PYXS 13F Institutional Holders
- PYXS Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- PYXS Insider Trading & SEC Form 4 Activity
- PYXS Articles
- Top Institutional Investor Stock Rankings